Andrea Wahner Hendrickson

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

Deborah K. Armstrong, Ronald D. Alvarez, Floor Backes et al. · Journal of the National Comprehensive Cancer Network · 2022 · 398 citations · Full text

Medicine, Gynecology, Oncology +16

NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Joyce F. Liu, Andrew Berchuck, Floor Backes et al. · Journal of the National Comprehensive Cancer Network · 2024 · 110 citations

Medicine, Gynecology, Oncology +13

Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers

Gerardo Colón‐Otero, Valentina Zanfagnin, Xiaonan Hou et al. · ESMO Open · 2020 · 93 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy.

Andrea Wahner Hendrickson, Paul Haluska · PubMed · 2009 · 39 citations

Medicine, Cancer Biology, Oncology +16

A Mixed-Methods Feasibility Trial of Protein Kinase C Iota Inhibition with Auranofin in Asymptomatic Ovarian Cancer Patients

Aminah Jatoi, Carmen Radecki Breitkopf, Nathan R. Foster et al. · Oncology · 2014 · 35 citations · Full text

Medicine, Oncology, Pharmacology +12